PHEOCHROMOCYTOMA
Clinical trials for PHEOCHROMOCYTOMA explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancer: drug shrinks tumors in early trial
Disease control OngoingThis study tests a daily pill called axitinib in adults with rare adrenal gland tumors (pheochromocytoma or paraganglioma) that have spread or cannot be removed. The main goal is to see how many patients' tumors shrink or disappear. Researchers also track how long the disease sta…
Matched conditions: PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated May 26, 2026 04:19 UTC
-
New hope for teens with rare tumors: targeted radiation drug under study
Disease control OngoingThis study looks at how safe a radioactive drug called Lutathera is for teenagers aged 12 to 18 with certain rare tumors of the gut or adrenal glands. The goal is to measure radiation doses to organs and track side effects. Lutathera is not a cure; it aims to control tumor growth…
Matched conditions: PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: Advanced Accelerator Applications • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
New hope for rare tumors: drug may slow cancer growth
Disease control OngoingThis study tests a drug called lanreotide in 10 people with advanced or metastatic paraganglioma or pheochromocytoma, rare tumors that release hormones. The goal is to see if lanreotide can slow tumor growth compared to before treatment. Participants receive injections every 4 we…
Matched conditions: PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
New scan could spot rare tumors earlier and more safely
Diagnosis OngoingThis study is testing a new type of PET/CT scan that uses a special tracer (68Ga-DOTATOC) to find neuroendocrine tumors and other related cancers. The goal is to see if this scan is safer and more sensitive than current imaging methods. About 800 people with known or suspected tu…
Matched conditions: PHEOCHROMOCYTOMA
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated May 26, 2026 03:56 UTC
-
New PET tracer could spot hidden tumors in kids
Diagnosis OngoingThis study tests a new radioactive tracer called 18F-DA for PET scans to see if it can find neuroblastoma and pheochromocytoma tumors more clearly than the current tracer. About 20 children and adults with known or suspected tumors will receive the tracer and be monitored for sid…
Matched conditions: PHEOCHROMOCYTOMA
Phase: EARLY_PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Diagnosis
Last updated May 15, 2026 11:54 UTC